| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |